0001209191-20-025596.txt : 20200424 0001209191-20-025596.hdr.sgml : 20200424 20200424161727 ACCESSION NUMBER: 0001209191-20-025596 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200422 FILED AS OF DATE: 20200424 DATE AS OF CHANGE: 20200424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Yuchun CENTRAL INDEX KEY: 0001334365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20815170 MAIL ADDRESS: STREET 1: 170 TRACER LA. CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-22 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001334365 Lee Yuchun C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2020-04-22 4 M 0 2000 57.27 A 3875 D Common Stock 2020-04-22 4 S 0 300 265.16 D 3575 D Common Stock 2020-04-22 4 S 0 300 266.18 D 3275 D Common Stock 2020-04-22 4 S 0 507 267.34 D 2768 D Common Stock 2020-04-22 4 S 0 224 268.48 D 2544 D Common Stock 2020-04-22 4 S 0 300 269.47 D 2244 D Common Stock 2020-04-22 4 S 0 369 270.54 D 1875 D Common Stock 2020-04-23 4 M 0 2000 57.27 A 3875 D Common Stock 2020-04-23 4 S 0 353 267.47 D 3522 D Common Stock 2020-04-23 4 S 0 200 269.23 D 3322 D Common Stock 2020-04-23 4 S 0 300 271.03 D 3022 D Common Stock 2020-04-23 4 S 0 100 272.55 D 2922 D Common Stock 2020-04-23 4 S 0 400 274.23 D 2522 D Common Stock 2020-04-23 4 S 0 600 275.90 D 1922 D Common Stock 2020-04-23 4 S 0 47 276.45 D 1875 D Stock Option (Right to Buy) 57.27 2020-04-22 4 M 0 2000 0.00 D 2022-09-13 Common Stock 2000 7125 D Stock Option (Right to Buy) 57.27 2020-04-23 4 M 0 2000 0.00 D 2022-09-13 Common Stock 2000 5125 D Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $265.16 (range $264.63 to $265.55). Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $266.18 (range $265.84 to $266.83). Open market sales reported on this line occurred at a weighted average price of $267.34 (range $267.09 to $267.67). Open market sales reported on this line occurred at a weighted average price of $268.48 (range $268.15 to $269.10). Open market sales reported on this line occurred at a weighted average price of $269.47 (range $269.23 to $269.60). Open market sales reported on this line occurred at a weighted average price of $270.54 (range $270.28 to $270.91). Open market sales reported on this line occurred at a weighted average price of $267.47 (range $267.04 to $267.97). Open market sales reported on this line occurred at a weighted average price of $269.23 (range $268.80 to $269.66). Open market sales reported on this line occurred at a weighted average price of $271.03 (range $270.69 to $271.65). Open market sales reported on this line occurred at a weighted average price of $274.23 (range $273.69 to $274.66). Open market sales reported on this line occurred at a weighted average price of $275.90 (range $275.44 to $276.40). Fully vested. /s/ Omar White, Attorney-in-Fact 2020-04-24